Korea
-
China remains one of the fastest growing pharmaceutical markets in the world
China and Japan will be the largest and second largest pharmaceutical markets in the Asia Pacific region in 2016.
Korea | 27 April 2012
-
PBS Biotech selects GCMS as exclusive bioreactor distributor in Korea
PBS Biotech Inc announced it has signed an exclusive distribution agreement in Korea with Green Cross Medical Sciences Corp (GCMS), one of Korea’s largest pharmaceutical firms. Under terms of the agreement GCMS will market, sell and support the com…
Korea | 27 July 2011
-
South Korea: Non-small cell lung cancer drug market trends
South Korea’s advanced medical and research infrastructure creates opportunities for pharmaceutical companies to expand current drug options and increase survival rates.
Korea | 01 July 2011
-
Invida forms partnership with Roche in Korea
Invida Group Pte Ltd announced that it has entered into a partnership agreement with Roche for the commercialization and marketing of that company’s primary care portfolio throughout Korea. According to the company, both Invida and Roche will benef…
Korea | 04 April 2011
-
South Korean hospitals increasingly adopt healthcare IT
South Korea, along with Japan and the Netherlands, is one of the few countries that prohibit the operation of profit-oriented hospitals. However, this trend is beginning to change with the first foreign, for-profit hospital being built in Songdo. The…
Korea | 15 March 2011
-
More Effective and Affordable Hepatitis Therapies Needed in Asia
China, Taiwan and South Korea represent endemic areas for viral hepatitis, with prevalence rates ranging from 4-13 percent for Hepatitis B (HBV) and from 1-4 percent for Hepatitis C (HCV). While there are several therapeutic options available fo…
Korea | 20 May 2010
-
Bayer Schering Kicks Off Antihypertensive Study in Asia
Bayer Schering Pharma has held two investigators meetings in Beijing, China and Seoul, Korea to announce the start of ADVISE, the Asia Pacific trial – nifeDipine in combination with Valsartan to achIeve blood preSsure targEts, a major phase IV stud…
Korea | 27 January 2010
-
Institut Pasteur Korea and NITD Singapore Collaborate on Tuberculosis Drug Discovery
Institut Pasteur Korea (IPK) and Novartis Institute for Tropical Diseases (NITD), Singapore, have entered into a Services Frame Agreement for the identification of safe and effective new therapies for Tuberculosis infected individuals. This part…
Korea | 23 December 2009
-
Institut Pasteur Korea to Screen Pfizer Compound Library in Collaboration with DNDi
Institut Pasteur Korea and the Drugs for Neglected Diseases Initiative (DNDi) have entered into a collaborative agreement, centered on the use of Pfizer’s compound library. This is for the identification and development of safe, effective and affor…
Korea | 16 December 2009
-
Biosimilar from Mycenax Completes Clinical Trials in Taiwan, South Korea
Mycenax Biotech has announced that its rheumatoid arthritis and psoriasis drug TuNEX, a biosimilar version of etanercept, has successfully completed a Phase I trial in South Korea and Phase I/II clinical trials in Taiwan. The company also announc…
Korea | 02 November 2009
